Responsibilities
Work with NPP stakeholders to identify knowledge gaps that can be addressed with MR and CI.
Leverage in-house data & analyses to identify need for primary research, inform approaches, and ensure results complement existing data, CI, and forecasts.
Design and execute primary market research projects, including defining business question(s), developing methodologies, managing vendors, analyzing study data, and communicating results, interpretations, and recommendations to a variety of cross-functional stakeholders.
Design and field primary CI investigations to inform pipeline development decisions. Collaborate with Alkermes CI team as needed.
Integrate data sources from a wide variety of studies, analyze data, and communicate insights and recommendations.
Quickly become an expert in assigned market(s), related commercial products, and any potential new markets.
Build a strong strategic partnership with NPP and serve as a key thought partner for NPP team to maximize insight leverage and business impact.
The Associate Director, Market Research and Competitive Intelligence (MRCI), Pipeline and Early Assets will be responsible for recommending, designing, and executing qualitative and quantitative primary market research to provide actionable information and insights to support Alkermes' early-stage pipeline. The role will work closely with the New Product Planning (NPP) group, and interface with clinical and commercial functions as needed to inform the development of pipeline products by understanding treatment provider, consumer, and payer perceptions.
Why join Team Alkermes?
Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.
We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts' Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.